Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016505265> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2016505265 endingPage "215" @default.
- W2016505265 startingPage "214" @default.
- W2016505265 abstract "We read with interest the Phase II study of Moreau et al.,1 evaluating four weekly infusions of single-agent rituximab (375 mg/m2) therapy in a cohort of patients with CD20+ multiple myeloma (MM) with either stage I, never treated disease, or stage III MM in relapse, or refractory after two lines of therapy. The authors concluded that rituximab as a single agent had minor activity in this cohort of patients with CD20 expression on at least 33% of tumor cells." @default.
- W2016505265 created "2016-06-24" @default.
- W2016505265 creator A5004152557 @default.
- W2016505265 creator A5033163324 @default.
- W2016505265 creator A5033220547 @default.
- W2016505265 creator A5057465226 @default.
- W2016505265 creator A5072775789 @default.
- W2016505265 date "2007-10-11" @default.
- W2016505265 modified "2023-10-17" @default.
- W2016505265 title "Reply to ‘Rituximab in CD20 positive multiple myeloma’ by P Moreau et al." @default.
- W2016505265 cites W1965906915 @default.
- W2016505265 cites W2045927984 @default.
- W2016505265 cites W2049526822 @default.
- W2016505265 cites W2103101762 @default.
- W2016505265 cites W2143882707 @default.
- W2016505265 doi "https://doi.org/10.1038/sj.leu.2404972" @default.
- W2016505265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17928885" @default.
- W2016505265 hasPublicationYear "2007" @default.
- W2016505265 type Work @default.
- W2016505265 sameAs 2016505265 @default.
- W2016505265 citedByCount "3" @default.
- W2016505265 countsByYear W20165052652012 @default.
- W2016505265 countsByYear W20165052652013 @default.
- W2016505265 crossrefType "journal-article" @default.
- W2016505265 hasAuthorship W2016505265A5004152557 @default.
- W2016505265 hasAuthorship W2016505265A5033163324 @default.
- W2016505265 hasAuthorship W2016505265A5033220547 @default.
- W2016505265 hasAuthorship W2016505265A5057465226 @default.
- W2016505265 hasAuthorship W2016505265A5072775789 @default.
- W2016505265 hasBestOaLocation W20165052651 @default.
- W2016505265 hasConcept C126322002 @default.
- W2016505265 hasConcept C143998085 @default.
- W2016505265 hasConcept C18031839 @default.
- W2016505265 hasConcept C2776063141 @default.
- W2016505265 hasConcept C2776364478 @default.
- W2016505265 hasConcept C2779338263 @default.
- W2016505265 hasConcept C2780653079 @default.
- W2016505265 hasConcept C71924100 @default.
- W2016505265 hasConceptScore W2016505265C126322002 @default.
- W2016505265 hasConceptScore W2016505265C143998085 @default.
- W2016505265 hasConceptScore W2016505265C18031839 @default.
- W2016505265 hasConceptScore W2016505265C2776063141 @default.
- W2016505265 hasConceptScore W2016505265C2776364478 @default.
- W2016505265 hasConceptScore W2016505265C2779338263 @default.
- W2016505265 hasConceptScore W2016505265C2780653079 @default.
- W2016505265 hasConceptScore W2016505265C71924100 @default.
- W2016505265 hasIssue "1" @default.
- W2016505265 hasLocation W20165052651 @default.
- W2016505265 hasLocation W20165052652 @default.
- W2016505265 hasOpenAccess W2016505265 @default.
- W2016505265 hasPrimaryLocation W20165052651 @default.
- W2016505265 hasRelatedWork W1969480819 @default.
- W2016505265 hasRelatedWork W2039226259 @default.
- W2016505265 hasRelatedWork W2049439131 @default.
- W2016505265 hasRelatedWork W2052365909 @default.
- W2016505265 hasRelatedWork W2118112957 @default.
- W2016505265 hasRelatedWork W2474837444 @default.
- W2016505265 hasRelatedWork W3126730168 @default.
- W2016505265 hasRelatedWork W3217566318 @default.
- W2016505265 hasRelatedWork W4297237848 @default.
- W2016505265 hasRelatedWork W1941943869 @default.
- W2016505265 hasVolume "22" @default.
- W2016505265 isParatext "false" @default.
- W2016505265 isRetracted "false" @default.
- W2016505265 magId "2016505265" @default.
- W2016505265 workType "article" @default.